Sex differences in the effects of cardiovascular medications, FWF, Lena Tschiderer, 2025
FFG Talente Praktikum, Georg Göbel
MYCOS – Azole antifungals in blood samples taken from the general population, MUI and UIBK, Faculty member: Peter Willeit, 2024
Austrian Digital Atrial Fibrillation Screening and Intervention, Ludwig Boltzmann Gesellschaft, Co-investigator: Peter Willeit, 2023
MeDeMSA – Medical Decision Making in Multiple System Atrophy, FWF, Co-investigator Georg Göbel, 2023
DigiCare, FFG, Georg Göbel, 2024
BBMRI.at #3, BMBWF, Georg Göbel
PRESENT – PREdictons for Science, Engineering N’Technology, FFG, Georg Göbel, 2023
Pain in Multiple System Athrophy, Multiple System Atrophy Coalition, Inc (USA), Co-investigator Georg Göbel
exoATwork – Exoskelette für manuelle Arbeitsplätze, FFG, Georg Göbel, 2022
REDUCE Study, Land Tirol, Peter Willeit, 2021
The Ischgl Follow-up-Study (FUPS-Ischgl), FWF, Katherine Bates, 2020
Sex differences in atherosclerosis and its clinical sequelae, FWF, Lena Tschiderer, 2021
Setting up and Contributing to a Common Service IT of BBMRI-ERIC AUT, Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium, Georg Göbel
LabMedData, FFG, Georg Göbel, 2019
Repeat cIMT measurement for predicting cardiovascular events, FWF, Peter Willeit, 2019
BBMRI.at #2, BMBWF, Georg Göbel
IScheckPlus – Standardisierung mitochondrialer Daten. FFG, Georg Göbel, 2017
BBMRI MUI, BMBWF, Georg Göbel
Role of Micro-RNA-122 in Cardiometabolic Diseases, FWF, Peter Willeit, 2015
Übergewicht, Bluthochdruck, Diabetes und erhöhte Blutfette als Risikofaktoren für Krebserkrankungen, OeNB, Hanno Ulmer, 2007